(Q34543015)

English

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Nicola Gökbuget

1

object named as

Nicola Gökbuget

0 references

5

object named as

Herve Dombret

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Nicola Gökbuget

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christina-Maria Hartog

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Renato Bassan

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Heinz-Gerd Derigs

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Richard Greil

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jesus-Maria Hernández-Rivas

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Francoise Huguet

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Tamara Intermesoli

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eric Jourdan

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christian Junghanss

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lothar Leimer

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Maria-Jose Moreno

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Albrecht Reichle

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Josep Ribera

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Matthias Schmid

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hubert Serve

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Matthias Stelljes

18

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Reingard Stuhlmann

19

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dieter Hoelzer

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

German Multicenter Study Group for Adult ALL and the European Working Group for Adult ALL

21

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

15 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

238-244

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Leukemia and the nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Central nervous system relapse in adults with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

7 July 2018

Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Treatment of adult acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031691

27 October 2018

Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meningeosis leukaemica in adult acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of Compassionate Therapy with Intrathecal Depot Liposomal Cytarabine in Acute Myeloid Leukemia Meningeosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.028092

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34543015&oldid=1625428215"